MIDLOTHIAN, Va., Oct. 22 VA-PARI-Respiratory
MIDLOTHIAN, Va., Oct. 22 /PRNewswire/ -- At CHEST 2008, PARI Respiratory
Equipment will present a comparative study of three commercially available,
breath-enhanced nebulizers and their in-vitro performance and delivery
efficiency of budesonide inhalation suspension (Pulmicort Respules,
AstraZeneca).
"Our goal in testing various breath-enhanced nebulizers is to help
clinicians consider respirable drug delivery rate to ensure patients receive
clinically effective doses," said Lisa Cambridge, director of clinical
development for PARI Respiratory Equipment, Inc.
The study compares the LC Sprint Reusable Nebulizer (PARI Respiratory
Equipment), LC PLUS Reusable Nebulizer (PARI Respiratory Equipment), and
Sidestream Plus reusable nebulizer (Respironics). Ms. Cambridge will present
the results on October 28th at 1pm in Philadelphia, PA at CHEST 2008, the
annual meeting of the American College of Chest Physicians.
About PARI Respiratory Equipment, Inc.
PARI is a leading worldwide developer and manufacturer of fast and
efficient aerosol delivery systems for patients with asthma, chronic lung
disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives
of those affected by respiratory diseases and those who care for them.
Maker of the world's leading breath-enhanced reusable nebulizer, the PARI
LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the
award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol
mask, and durable PARI PRONEB Ultra II. PARI's Vortex anti-static valved
holding chamber improves the aerosol deposition of metered dose inhalers
(MDI's). PARI's North American headquarters is in Midlothian, VA with
worldwide headquarters in Starnberg, Germany. Online at http://www.Pari.com
Additional information is available by contacting Ayars & Associates at
805-845-5682 or Ashley Weigand at 804-253-7274 x711.
SOURCE PARI Respiratory Equipment, Inc.
